Formulation and Characterization Strategies for Gene Therapies
Summary: Formulation studies for gene therapy products are currently limited in scope and revolve around gathering stability data at frozen storage conditions. A systematic approach towards understanding degradation mechanisms followed by buffer and excipient selection is required. In this on-demand webinar, our expert discusses how Catalent Cell & Gene Therapy is working towards an approach for gathering product knowledge and establishing formulation selection criteria using traditional/routine techniques that are historically used for biologics formulations, as well as evaluating novel methodologies for gene therapy products.